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MalA is an -glucosidase from the hyperthermophilic archaeon Sulfolobus
solfataricus. It belongs to glycoside hydrolase family 31, which includes several
medically interesting -glucosidases. MalA and its selenomethionine derivative
have been overproduced in Escherichia coli and crystallized in four different
crystal forms. Microseeding was essential for the formation of good-quality
crystals of forms 2 and 4. For three of the crystal forms (2, 3 and 4) full data sets
could be collected. The most suitable crystals for structure determination are the
monoclinic form 4 crystals, belonging to space group P21, from which data sets
extending to 2.5 Å resolution have been collected. Self-rotation functions
calculated for this form and for the orthorhombic (P212121) form 2 indicate the
presence of six molecules in the asymmetric unit related by 32 symmetry.
1. Introduction
-Glucosidases (EC 3.2.1.20; -d-glucoside glucohydrolases) are exoacting enzymes which cleave the terminal glucose moiety from the
non-reducing end of their substrates. This group of enzymes play
essential roles in carbohydrate metabolism and in glycoprotein
processing. They catalyze the release of glucose from oligosaccharides and storage polymers such as starch and glycogen. Regulation of
-glucosidase activity helps to control glucose levels and therefore
several of these enzymes are among drug targets for type 2 diabetes
(Cheng & Fantus, 2005). Deficiency or malfunction of the human acid
-glucosidase causes accumulation of glycogen in the lysosomes, a
condition known as glycogen-storage disease II (Pompe’s disease).
The endoplasmic reticulum -glucosidases catalyze processing of
N-linked oligosaccharides in the quality-control system for glycoprotein folding and maturation; inhibitors of these enzymes have
potential as antiviral agents (Mehta et al., 1998).
In the glycoside hydrolase classification (Henrissat, 1991; Henrissat
& Bairoch, 1993; http://afmb.cnrs-mrs.fr/cazy/CAZY/index), -glucosidases are found mainly in two families: GH13 and GH31. Most
-glucosidases from higher organisms belong to the GH31 family.
This family comprises proteins displaying a range of different
enzymatic activities ( -glucosidase, -xylosidase, -1,4-glucan lyase,
6- -glucosyltransferase and 3- -isomaltosyltransferase) with very
broad substrate specificities (Frandsen & Svensson, 1998). Structural
information for the GH31 family is currently limited to an
-xylosidase from Escherichia coli (Lovering et al., 2005).
MalA is an -glucosidase from the hyperthermophilic archaeon
Sulfolobus solfataricus, with a substrate preference for maltose and
maltooligosaccharides (Rolfsmeier & Blum, 1995). It consists of 693
amino-acid residues and has a molecular weight of 80.4 kDa. Since
proteins from thermophilic organisms are often more amenable to
crystallization, MalA was chosen as a crystallization target representing the -glucosidase specificity in GH31.

2. Materials and methods
2.1. Construction of a plasmid for overproduction of MalA
# 2005 International Union of Crystallography
All rights reserved
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Standard molecular-biology methods for cloning and manipulation
of DNA were used (Sambrook et al., 1989). The entire coding region
of malA was obtained by PCR with Turbo Pfu DNA polymerase
doi:10.1107/S1744309105035177
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Table 1
Crystal data and data-collection statistics.
Values in parentheses refer to the highest resolution shell.

Crystallization conditions

Cryocooling conditions
Beamline
Detector
Wavelength (Å)
Space group
Unit-cell parameters
a (Å)
b (Å)
c (Å)
( )
Molecules per ASU
Resolution range (Å)
Unique reflections
Observed reflections
Rmrgd-F} (%)
hI/(I)i
Completeness (%)
Redundancy

Form 2

Form 3

Form 4

Form 4b

MalA

SeMet-MalA

SeMet-MalA

MalA

4 mg ml1 MalA,
11% PEG 4000,
0.1 M sodium acetate pH 4.1,
0.2 M sodium citrate,
microseeding (form 2)
25% glycerol
ID14-2, ESRF
ADSC Q4R CCD
0.9330
P212121

3 mg ml1 SeMet-MalA,
31% PEE797†,
0.1 M sodium acetate pH 4.0,
10 mM DTT‡
—
ID14-2, ESRF
ADSC Q4R CCD
0.9330
P21

4 mg ml1 SeMet-MalA,
11% PEG 4000,
0.1 M sodium acetate pH 4.1,
0.2 M sodium citrate,
microseeding (form 2)
25% glycerol, annealed
ID23-1, ESRF
MAR Mosaic 225 CCD
0.9791
P21

4 mg ml1 MalA,
10% PEG 4000,
0.1 M sodium acetate pH 4.2,
0.2 M sodium citrate,
0.5% BOG§, microseeding (form 2)
25% glycerol, annealed
ID14-1, ESRF
ADSC Q4 CCD
0.9340
P21

321.5
158.2
320.6
119.9
21–48
35–4.0 (4.2–4.0)
231876
842228
14.7 (23.5)
7.2 (4.9)
97.4 (95.6)
3.6 (3.7)

103.2
173.6
154.1
108.0
4–9
35–2.55 (2.65–2.55)
167413
1262798
6.3 (18.2)
16.8 (7.1)
99.2 (98.5)
7.5 (7.5)

100.1
174.4
144.0
109.1
4–8
35–2.50 (2.63–2.50)
154886
398868
9.6 (30.5)
11.7 (5.3)
95.2 (95.8)
2.6 (2.3)

97.3
192.8
281.7
4–8
35–3.0 (3.1–3.0)
105696
787671
5.6 (16.1)
20.3 (7.6)
98.6 (95.4)
7.4 (7.1)

† PEE797, pentaerythritol ethoxylate (15/4 EO/OH). ‡ DTT, dithiothreitol. § BOG, -octylglucopyranoside. } Rmrgd-F reflects the quality of the reduced amplitudes considering
the gain in accuracy resulting from data redundancy (Diederichs & Karplus, 1997).

(Stratagene) used according to the supplier’s recommendations with
the vector pB122 (Rolfsmeier et al., 1998) as a template. The oligonucleotide primers SSMALA-5, 50 -CGGGATCCTAAAAATATACGAGAACAAAGGC-30 , and SSMALA-3, 50 -AACTGCAGCTACTCTAGGTTAATCTTTCCCC-30 , were used. These introduce unique
BamHI and PstI restriction sites (shown in italics) at the 50 - and
30 -ends of the PCR product, respectively. Following digestion with the
restriction enzymes BamHI and PstI, the PCR product was ligated
into the vector pUHE 23-2 (Lutz & Bujard, 1997), resulting in the
plasmid pMW800. E. coli strain NF1830 (Jensen et al., 1992) was
transformed with pMW800 to allow IPTG (isopropyl- -d-thiogalactopyranoside) controlled production of MalA. Owing to the
cloning strategy, the first four amino acids of MalA (1MQTI) are
changed to 1MRIL in the recombinant protein.
2.2. Overexpression and purification

A 5 ml overnight culture of the MalA-overproducing strain grown
at 310 K in LB medium (Sambrook et al., 1989) supplemented with
ampicillin (100 mg ml1) was transferred to 1 l of the same medium
and growth was continued at 310 K. When the culture reached an
OD436 of 0.8–1, IPTG was added to a final concentration of 1 mM and
incubation of the culture was continued overnight. The cells were
harvested by centrifugation in a Sorvall centrifuge (SLA3000 rotor)
at 8000 rev min1 for 5 min. The cell paste was washed in 50 mM
Tris–HCl pH 7.5, 100 mM NaCl, recovered by centrifugation as above
and resuspended in 40 ml of the same buffer. The cells were lysed by
sonication and the cell debris was removed by centrifugation in the
Sorvall centrifuge (SS34 rotor, 14 000 rev min1, 30 min). The cell
extract, diluted to 80 ml in the same buffer, was stirred gently while
placed in a water bath preheated to 358 K. When the temperature of
the cell extract reached 348 K it was allowed to stand for 10 min and
then put on ice. The precipitate was removed by centrifugation. The
supernatant was then brought to 50% saturation with ammonium
sulfate on ice and the precipitate was recovered by centrifugation.
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The precipitate was redissolved in 4 ml 20 mM Tris–HCl pH 7.5,
20 mM NaCl and dialysed against the same buffer at 277 K. The
dialysed protein was applied onto a 5 ml HiTrap Q column (Pharmacia) and eluted with a gradient of 20–500 mM NaCl in 20 mM Tris–
HCl pH 7.5. MalA eluted as a single peak around 50 mM NaCl.
Subsequently, the sample was loaded onto a HiLoad 26/60 Superdex
200 gel-filtration column (Pharmacia) equilibrated with 50 mM Tris–
HCl pH 7.5, 150 mM NaCl and eluted using a flow rate of
0.5 ml min1. The above procedure yielded about 10 mg of protein
which was more than 95% pure as judged from SDS–PAGE. For
preparation of the selenomethionine-substituted MalA (SeMetMalA), the overproducing strain was grown as previously described
(Duyne et al., 1993; Doublié, 1997) and the enzyme was purified as
described above.
The substitutions at the N-terminus of the recombinant protein
were confirmed by N-terminal sequencing (1MRILKIYENK).
Peptide mapping of a tryptic digest of MalA by MALDI–TOF mass
spectrometry resulted in about one-third sequence coverage,
although the terminal peptides were not seen. MalA and SeMetMalA were assayed for -glucosidase activity as described by Rolfsmeier & Blum (1995) using p-nitrophenyl- -d-glucopyranoside as
substrate.
2.3. Crystallization

Crystals were grown at room temperature by the hanging-drop
vapour-diffusion method using protein stock solutions of 2–
5 mg ml1 in 20 mM Tris–HCl pH 7.5, 20 mM NaCl. Drops consisting
of 2 ml protein and 3 ml reservoir solution were equilibrated over
1000 ml reservoirs. In the initial solubility (Stura et al., 1992) and
sparse-matrix (Hampton Research Crystal Screen 1; Jancarik & Kim,
1991) screens, organic polymers generally produced crystalline
precipitates. A variety of morphologically different crystals were
subsequently obtained in a tailor-made screen with lower concentration of polyethylene glycol 4000 [PEG 4000, 10%(w/v)], 0.2 M salt
Acta Cryst. (2005). F61, 1039–1042
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Figure 1
Crystals of MalA. (a) Form 1, maximum dimensions 0.1  0.2  0.02 mm; (b) form 2, maximum dimensions 0.3  0.05  0.05 mm; (c) form 3, maximum dimensions 0.15  0.1
 0.1 mm; (d) form 4, irregular formations with maximum thickness around 0.04 mm; (e) form 4b, maximum dimensions 0.6  0.1  0.05 mm. Crystallization conditions for
crystal forms 2–4b are given in Table 1. The form 1 crystals shown in (a) were grown from 0.1 M Tris–HCl pH 8, 0.2 M ammonium sulfate, 10% PEG 4000 using a protein
concentration of 3.9 mg ml1.

3. Results and discussion

content of between 30 and 70%. The form 1 crystals were obtained
under a range of different conditions, mostly at pH values above 7
where the protein carries a negative net charge (pI ’ 5.5). Diffraction
test images showed unit-cell parameters very similar to those of the
orthorhombic form 2 crystals (Table 1), but severe disorder in at least
one direction hampered data collection. In contrast, the form 2
crystals displayed ordered diffraction and complete data sets
extending to approximately 3 Å resolution could be collected. The
form 3 crystals diffracted X-rays beyond 2.5 Å, but a very large unit
cell (Table 1) caused considerable problems with overlapping
reflections and data could only be processed to around 4 Å. Despite
the pseudo-hexagonal geometry of the unit cell (a = 321.5, b = 158.2,
c = 320.6 Å, = 119.9 ), the diffraction pattern only obeys monoclinic
symmetry (P21). This corresponds to 21–48 molecules per asymmetric
unit, which together with the problems in data acquisition renders
this crystal form unsuitable for structure determination. Notably, the
crystals of irregular shape (Figs. 1d and 1e) obtained in a few
instances after microseeding with the form 2 crystals diffracted to a
resolution limit beyond 2.5 Å. These crystals both belong to the
monoclinic space group P21 and show similar, but not identical, unitcell parameters (Table 1). Consequently, they have been denoted
form 4 (SeMet MalA; Fig. 1d) and form 4b (MalA; Fig. 1e), respectively. Crystal-packing densities suggest that the asymmetric unit
contains four to eight molecules. The self-rotation functions for the
form 2 and the form 4 data, calculated with the programs MOLREP
(Vagin & Teplyakov, 1997), AMoRe (Navaza, 1994) and POLARRFN
(Collaborative Computational Project, Number 4, 1994), revealed the
presence of non-crystallographic twofold and threefold symmetry
axes. In both cases, a group of NCS symmetry elements compatible
with 32 point-group symmetry could be identified, which indicates the
presence of six molecules in the asymmetric unit. Data collected from
the SeMet-substituted protein (form 4) did not contain sufficient
anomalous signal for phasing. This could be a consequence of
incomplete substitution. Structure determination is therefore being
pursued by molecular replacement using the recently reported
structure of the GH31 -xylosidase YicI from E. coli (PDB code 1xsi;
Lovering et al., 2005) as a search model.

Construction of a new overexpression system in E. coli allowed the
production of recombinant MalA in large quantities. The specific
activities of MalA and SeMet MalA were comparable to previous
reports on the native and recombinant enzyme (Rolfsmeier & Blum,
1995; Rolfsmeier et al., 1998). A variety of crystal forms (Fig. 1) have
been obtained and characterized by X-ray diffraction (Table 1). Only
minor differences were observed in the crystallization behaviour of
SeMet MalA and unsubstituted MalA and the diffraction quality of
the resulting crystals was similar. Space groups were assigned based
on averaging statistics and systematic absences, and the number of
molecules in the asymmetric unit was estimated assuming a solvent

The authors would like to thank Dorthe Boelskifte for assistance in
protein purification, Christine Finnie and Birte Svensson (Carlsberg
Laboratory, Valby, Denmark) for help in peptide mapping by mass
spectrometry and Flemming Hansen for help in crystal handling.
Provision of beamtime at MAXLAB (Lund, Sweeden) and the
European Synchrotron Radiation Facility (ESRF, Grenoble, France)
is gratefully acknowledged. This study was supported by the
European Union under the Cell Factory of the Fifth Framework
Program, QLK3-2001-02400 (NEPSA), the Danish National

(ammonium sulfate, sodium dihydrogen phosphate or sodium citrate)
and covering the pH interval 4–8. Rosettes of roundish plates (form 1,
Fig. 1a) were obtained at high pH (7–8.5) with either ammonium
sulfate or sodium dihydrogen phosphate. At low pH (4–5) and in the
presence of citrate, bundles of thin needles were formed (form 2).
Owing to the apparent preference for polymeric precipitating agents,
separate screens based on different types of organic polymers,
pentaerythritol propoxylates and pentaerythritol ethoxylates (Gulick
et al., 2002), were designed. Crystals of hexagonal shape (form 3,
Fig. 1c) grew from high concentrations of pentaerythritol ethoxylate
(15/4 EO/OH; PEE797) at pH 4. Each crystal form was optimized
using fine grid screens with variations in pH, concentration of the salt,
polymer or protein and in the relative volume of protein solution and
reservoir in the drop. Usually, crystals formed within 3–10 d. Microseeding proved essential for reproducible growth of single crystals of
form 2 (Fig. 1b). In a few cases, crystals displaying different
morphologies (Figs. 1d and 1e) formed prior to the form 2 crystals in
the optimization experiments where microseeding was used. Optimized crystallization conditions for crystals of forms 2–4b that could
be used for data collection are summarized in Table 1.
2.4. Data collection and processing

Initial diffraction tests were performed at I711, MAXLAB (Lund,
Sweden). Diffraction data were collected at cryogenic temperatures
using solutions consisting of reservoir composition supplemented
with 25% glycerol for cryoprotection. One exception is the form 3
crystals, which were flash-cooled directly from the mother liquor, as
PEE797 itself acts as a cryoprotectant at high concentrations. Various
beamlines (ID14-1, ID14-2, ID14-4 and ID23-1) at the European
Synchrotron Radiation Facility (ESRF, Grenoble, France) were used
for further testing and data collection (Table 1). Data were processed
with XDS (Kabsch, 1993) and scaled using XSCALE. Statistics for
the best data set collected for each crystal form are shown in Table 1.

Acta Cryst. (2005). F61, 1039–1042
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